Key result
A systematic review of 43 studies identified 24 continuous fetal monitoring devices, but found no specific approach or design to be advantageous due to high inter-device and intra-device variability.
Why the study?
Current antepartum fetal monitoring methods are intermittent snapshot assessments that may miss signs of demise, prompting this review to map the design and performance of continuous fetal monitoring devices.
Systematic Review (n=43)
A systematic review of continuous fetal monitoring devices reveals high variability in design and performance, highlighting the need for standardized assessment methods.
High variability advises caution in device selection; challenges superiority claims and supports standardized validation.
BACKGROUND: Antepartum fetal monitoring aims to assess fetal development and wellbeing throughout pregnancy. Current methods utilised in clinical practice are intermittent and only provide a 'snapshot' of fetal wellbeing, thus key signs of fetal demise could be missed. Continuous fetal monitoring (CFM) offers the potential to alleviate these issues by providing an objective and longitudinal overview of fetal status. Various CFM devices exist within literature; this review planned to provide a systematic overview of these devices, and specifically aimed to map the devices' design, performance and factors which affect this, whilst determining any gaps in development. METHODS: A systematic search was conducted using MEDLINE, EMBASE, CINAHL, EMCARE, BNI, Cochrane Library, Web of Science and Pubmed databases. Following the deletion of duplicates, the articles' titles and abstracts were screened and suitable papers underwent a full-text assessment prior to inclusion in the review by two independent assessors. RESULTS: The literature searches generated 4,885 hits from which 43 studies were included in the review. Twenty-four different devices were identified utilising four suitable CFM technologies: fetal electrocardiography, fetal phonocardiography, accelerometry and fetal vectorcardiography. The devices adopted various designs and signal processing methods. There was no common means of device performance assessment between different devices, which limited comparison. The device performance of fetal electrocardiography was reduced between 28 to 36 weeks' gestation and during high levels of maternal movement, and increased during night-time rest. Other factors, including maternal body mass index, fetal position, recording location, uterine activity, amniotic fluid index, number of fetuses and smoking status, as well as factors which affected alternative technologies had equivocal effects and require further investigation. CONCLUSIONS: A variety of CFM devices have been developed, however no specific approach or design appears to be advantageous due to high levels of inter-device and intra-device variability.
No takes yet. Share an insight, caveat, or question.
Tamber et al. (2020) conducted a systematic review in Pregnancy / Fetal monitoring (n=43). Continuous fetal monitoring devices was evaluated on Device design and performance. A systematic review of 43 studies identified 24 continuous fetal monitoring devices, but found no specific approach or design to be advantageous due to high inter-device and intra-device variability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: